Sumalate® is a registered trademark of Albion Laboratories,Inc., covered by one or more claims of U.S. Patent Nos. 6,716,814; 8,007,846; and 8,425,956.
Quatrefolic® is a registered trademark of Gnosis, SpA, covered by one or more claims of U.S. Patent # 7,947,662 CAS # 1181972-37-1
Unless otherwise noted, all individuals depicted are models used for illustrative purposes only.
REFERENCES: 1. Chromagen® Prescribing Information, Avion Pharmaceuticals, LLC, 2022. 2. Bovell-Benjamin AC, Viteri FE, and Allen LH. Iron absorption from ferrous bisglycinate and ferric trisglycinate in whole maize is regulated by iron status. Am J Clin Nutr. 2000; 71:1563–1569. 3. Edited by Allen, L, de Benoist B, Dary O,Hurrel R. Guidelines on food fortification with micronutrients. World Health Organization and Food and Agricultural Organization of the United Nations.2006; 97-100. 4. Piskin, E., Cianciosi, D., Gulec, S., Tomas, M., & Capanoglu, E. (2022). Iron Absorption: Factors, Limitations, and Improvement Methods. ACS omega, 7(24), 20441–20456. https://doi.org/10.1021/acsomega.2c01833. 5. Cepeda-Lopez, A. C.; Melse-Boonstra, A.; Zimmermann, M. B.;
Herter-Aeberli, I. In Overweight and Obese Women, Dietary Iron Absorption Is Reduced and the Enhancement of Iron Absorption by Ascorbic Acid Is One-half That in Normal-Weight Women. Am. J. Clin. Nutr. 2015, 102 (6), 1389−1397. 6. Lamers Y, Prinz-Langenohl R, Brämswig S, Pietrzik K. Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age. Am J Clin Nutr. 2006;84(1):156-161. doi:10.1093/ajcn/84.1.156.
This content is for informational and educational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, pediatrician, or other qualified health provider with any questions you may have regarding diet and exercise during and after pregnancy, or other medical condition. For more information, please see our Terms of Use.
WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
DESCRIPTION: Chromagen® for oral administration is an iron supplement softgel that is pearlescent dark blue and embossed with “CH75” on one side.
OTHER INGREDIENTS: Gelatin capsule (bovine gelatin, Candurin® Blue Shimmer (mica-based pearlescent pigment), caramel coloring, carob, glycerin, FD&C Blue #1, purified water), beeswax Soybean oil and soy lecithin.
INDICATIONS: Chromagen® is a multivitamin/ multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency.
CONTRAINDICATIONS: Chromagen® is contraindicated in patients with a known hypersensitivity to any of the ingredients.
PRECAUTIONS: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.
ADVERSE REACTIONS: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
DOSAGE AND ADMINISTRATION: One softgel daily, or as directed by a physician.
HOW SUPPLIED: Bottles of 30 softgels (75854-320-30). The listed product number is not a National Drug Code. Instead, Avion Pharmaceuticals has assigned a product code formatted according to standard industry practice to meet the formatting requirements of pharmacy and healthcare insurance computer systems.
STORAGE: Store at 20° - 25°C (68° - 77°F); excursions permitted to 15° - 30°C (59° - 86°F). [See USP Controlled Room Temperature.]
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
You may report side effects to Avion Pharmaceuticals, LLC at 1-888-612-8466 or to the FDA at 1-800-FDA-1088.
Please click here for full Prescribing Information,
including Boxed Warning.
